ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Task Force: No Routine Mammograms Until 50

November 20, 2009

AACR President Kripke Calls For Dedicated Translational Research

March 11, 1994

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

July 27, 1984